| Stage | ZVRA | % of rev | LLY | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $38M | 100.00% | $24.4B | 100.00% | LLY ×646.18 |
| Gross profit | $36M | 95.25% | $20.5B | 83.88% | ZVRA +11.4pp |
| Operating income | $12M | 30.67% | $8.6B | 35.28% | LLY +4.6pp |
| Pre-tax income | $20M | 52.22% | $8.4B | 34.46% | ZVRA +17.8pp |
| Net income | $19M | 50.87% | $6.5B | 26.44% | ZVRA +24.4pp |
| Stage | ZVRA | LLY | Gap · A − B |
|---|---|---|---|
| Revenue | $38M100.00% | $24.4B100.00% | LLY ×646.18 |
| Gross profit | 95.25%$36M | 83.88%$20.5B | ZVRA +11.4pp |
| Operating income | 30.67%$12M | 35.28%$8.6B | LLY +4.6pp |
| Pre-tax income | 52.22%$20M | 34.46%$8.4B | ZVRA +17.8pp |
| Net income |
| 50.87%$19M |
| 26.44%$6.5B |
| ZVRA +24.4pp |
No shared counterparties.